Related by context. All words. (Click for frequent words.) 68 cognitive affective 67 somatic symptoms 67 alexithymia 66 HRQOL 64 psychiatric comorbidities 64 psychiatric morbidity 64 symptom severity 64 somatic complaints 64 hypochondriasis 64 convergent validity 63 autonomic dysfunction 63 psychiatric comorbidity 63 premorbid 63 HRQL 63 differential gene expression 63 depressive symptom 63 somatoform disorders 63 SRBD 63 Subgroup analyzes 62 neurosensory 62 predictive validity 62 subscale scores 62 hyperactivity inattention 62 exploratory endpoints 62 depressive symptomatology 62 affective psychoses 62 psychosocial functioning 62 interobserver 62 etiologic 61 Logistic regression 61 subthreshold 61 neuroanatomical 61 comorbid depression 61 coronary stenosis 61 Depressive symptoms 61 subclinical atherosclerosis 61 CORE OM 61 Descriptive statistics 61 Symptom severity 61 Multiple logistic regression 61 metabolic parameters 61 HRQoL 61 Multivariate analysis 61 inattention hyperactivity 61 neurocognitive impairment 61 covariate 60 Suicidal ideation 60 electrophysiologic 60 intraobserver 60 Brief Psychiatric 60 internalizing disorders 60 affective disorders 60 clinicopathological features 60 hematopoietic cancers 60 MMSE score 60 bronchopulmonary dysplasia BPD 60 vascular endothelial dysfunction 60 neurocognitive functioning 60 interrater reliability 60 HAM D# 60 psychometric properties 60 Multivariate logistic regression 60 prostate carcinogenesis 60 Index CDAI 60 glomerular filtration 60 methodologic 60 NIH CPSI 59 logistic regression model 59 explanatory variables 59 neuropsychological assessment 59 logistic regression analyzes 59 Primary endpoints 59 euthymic patients 59 subscales 59 psychobiological 59 cardiometabolic syndrome 59 postoperative AF 59 HAMD 59 airway responsiveness 59 generalized epilepsy 59 extrapyramidal symptoms 59 plain radiographs 59 #q# deletion syndrome 59 oncologic outcomes 59 metabolite concentrations 59 Secondary efficacy endpoints 59 atherothrombotic 59 Multiple linear regression 59 elevated ALT 59 serologically active patients 59 sociodemographic factors 59 Sociodemographic 59 clinicopathological 59 elevated IOP 59 logistic regression models 59 left ventricular diastolic 59 mucosal inflammation 59 WOMAC pain 59 hyperarousal 59 neuroimaging studies 59 extrapyramidal 59 endophenotypes 59 Global Impression CGI 59 virologic responses 59 neurologic complications 59 carotid IMT 58 neuropsychological impairments 58 suicide attempters 58 HRCT 58 unmeasured confounding 58 observable behaviors 58 conditional logistic regression 58 internalizing behaviors 58 Logistic regression analysis 58 emotional dysregulation 58 comorbid disorders 58 AST ALT 58 intraclass correlation coefficients 58 pathophysiological mechanisms 58 proton MR spectroscopy 58 cardiac autonomic 58 cytologic 58 syndromal 58 sensory gating 58 hepatic lesions 58 multivariate analyzes 58 externalizing disorders 58 androgen depletion 58 Likert scale 58 behavioral disinhibition 58 plasma pharmacokinetics 58 neurocognitive function 58 prognostic variables 58 neurodevelopmental outcome 58 correlation coefficients 58 erection hardness 58 EQ 5D 58 symptomatology 58 bivariate analysis 58 Cronbach alpha 58 neuropsychological functioning 58 noncognitive 58 meta analytic 58 definite stent thrombosis 58 sociodemographic variables 58 airway hyperresponsiveness 58 Endothelial dysfunction 58 residual confounding 58 Health Assessment Questionnaire 58 dyspnoea 58 sociodemographic characteristics 58 randomized controlled trials RCTs 58 neurologic symptoms 58 lability 58 somatoform disorder 58 neurocognitive deficits 58 symptom checklist 58 CPAP adherence 58 mania hypomania 58 carcinomatosis 58 atherothrombotic disease 58 LUTS 58 diastolic pressures 58 Meta analyzes 58 IBDQ 58 glial tumors 58 interobserver reliability 58 subscore 58 schizotypal traits 58 scintigraphic 58 thyrotropin 58 nonexposed 57 dose proportionality 57 subscores 57 unmeasured confounders 57 psychosocial variables 57 affective psychosis 57 cognitive domains 57 schizophreniform disorder 57 extrapyramidal symptoms EPS 57 comorbid psychiatric 57 atrophic gastritis 57 Atopic 57 Cardiorespiratory fitness 57 glaucomatous 57 renal scarring 57 adjuvant systemic 57 HER2 expression 57 acetabular dysplasia 57 posttreatment 57 allostatic load 57 chi squared 57 Interrater reliability 57 histological subtype 57 multiple logistic regression 57 Poisson regression 57 pharmacodynamic parameters 57 univariate 57 neuropsychiatric symptoms 57 physiological arousal 57 MMSE scores 57 T2DM 57 aetiology 57 Kaplan Meier curve 57 psychodynamic psychotherapy 57 ADCS CGIC 57 Secondary endpoints 57 psychophysiological 57 cerebellar vermis 57 comorbidity 57 rCBF 57 biochemical abnormalities 57 multivariate regression analysis 57 aminotransferases 57 AUDs 57 serum PTH 57 clinicopathologic 57 nonpharmacologic 57 albumin excretion rate 57 Neuropsychiatric Inventory NPI 57 odds ratios ORs 57 probiotic supplementation 57 thromboembolic complications 57 Rating Scale BPRS 57 hypovolemia 57 HER2 overexpression 57 autoimmune thyroid 57 aminotransferase levels 57 plasma cortisol 57 socioeconomic variables 57 comorbid anxiety 57 semiquantitative 57 Akathisia 57 hematologic parameters 57 aldosterone antagonist 57 confidence intervals CIs 57 Neuroticism 57 univariate analyzes 57 cardiometabolic risk 57 PCWP 57 prostate cancer PCa 57 transaminase elevations 57 angiographically 57 serum BDNF 57 System IPSS 57 Mood disorders 57 Efficacy endpoints 57 CP CPPS 57 hyperhomocysteinemia 57 intima media thickness 57 cholinergic tone 57 point Likert scale 57 Univariate 57 Heritability 57 hyperprolactinemia 57 neuropsychiatric diseases 57 albumin excretion 56 laterality 56 inflammatory biomarkers 56 antidepressant efficacy 56 neuropathologic 56 neurophysiologic 56 Ganetespib 56 BPS IC 56 pulvinar 56 chromium picolinate supplementation 56 STRATEGY FOR AN OPEN 56 dissociative symptoms 56 metabolic dysfunction 56 UGT#A# * 56 HbA 1C 56 schizotypal 56 urolithiasis 56 meta regression 56 YMRS 56 elevated serum creatinine 56 subjective sleepiness 56 symptom exacerbation 56 spirometric 56 genotypic resistance 56 Crohn Disease Activity 56 euthymic 56 LV ejection fraction 56 body habitus 56 pharmacodynamic markers 56 inducible ischemia 56 comorbid 56 HAQ DI 56 prognostic significance 56 bivariate 56 metabolic syndrome MetS 56 autistic traits 56 abdominal adiposity 56 neurological abnormalities 56 metacognitive 56 #F FDG PET 56 depression suicidal ideation 56 agitation irritability 56 Child Behavior Checklist 56 FDG uptake 56 hamartomas 56 Visual Analogue Scale VAS 56 salivary cortisol 56 posttraumatic 56 fetal chromosomal 56 Lumbar spine 56 microscopic hematuria 56 CLBP 56 aetiological 56 APOE genotype 56 prodromal 56 unipolar depression 56 alanine aminotransferase ALT 56 comorbid conditions 56 viral etiology 56 nodal metastasis 56 atherogenic dyslipidemia 56 BPRS 56 anti JCV antibodies 56 abnormal lipid 56 extramedullary 56 avoidant personality disorder 56 histopathologic 56 tolerability pharmacokinetics 56 underlying pathophysiology 56 histopathological 56 multivariate Cox 56 intact parathyroid hormone 56 hyperalgesia 56 syndromic 56 BMI z 56 pathophysiological 56 histologic subtype 56 Visual acuity 56 emotional lability 56 myeloproliferative diseases 56 electroencephalographic 56 impaired cognition 56 oxygen desaturation 56 protein tyrosine phosphatase 56 TEAEs 56 atypical antipsychotic medications 56 prostate cancer CaP 56 immunological responses 56 ecchymosis 56 Sleep disordered breathing 56 T1DM 56 CONCERTA ® 56 EBV infection 56 parkinsonism 56 nodal metastases 56 plasma lipid 56 mitochondrial toxicity 56 Histopathologic 56 poststroke 56 unmeasured factors 56 subthreshold depression 56 Index FSFI 56 orofacial clefts 56 SGRQ 56 dyslipidaemia 56 symptomatic VTE 56 prognostic indicators 56 carotid stenosis 56 GH deficiency 56 ANCOVA 56 bivariate analyzes 56 attention-deficit/hyperactivity disorder ADHD 56 ictal 56 corneal thickness 56 Distress Scale 56 hypoperfusion 56 corticosteroid dose 56 subsyndromal 56 radiographic findings 56 primary aldosteronism 56 hemodynamic measurements 56 erythrocyte sedimentation rate 56 DLQI 56 Platelet counts 56 antioxidant supplementation 56 Histologic 56 coagulopathy 56 Cognitive impairment 55 silent myocardial ischemia 55 tumorigenicity 55 SGPT 55 Fibromyalgia Impact Questionnaire 55 mg BID dose 55 histologic subtypes 55 daytime somnolence 55 tic severity 55 linear pharmacokinetics 55 neurologic dysfunction 55 Multivariate analyzes 55 Montgomery Åsberg Depression 55 echogenicity 55 ecotoxicological 55 genetic polymorphisms 55 Nonspecific 55 esophageal reflux 55 visceral adiposity 55 calculi 55 hepatic steatosis 55 Preoperatively 55 plasma creatinine 55 hypopneas 55 extrapyramidal side 55 perceptual reasoning 55 serum urate levels 55 interindividual variability 55 elevated homocysteine 55 Leydig cell 55 parasomnias 55 SSRI SNRI 55 eosinophilia 55 induced sputum 55 SUVmax 55 serum leptin 55 epileptogenic 55 methodological limitations 55 STEP BD 55 Scale Cognitive Subscale 55 pharmacodynamic endpoints 55 posterior cingulate 55 ADAS Cog 55 psychopathology 55 serum antibodies 55 hallux valgus 55 hypercalciuria 55 sonographic findings 55 medial frontal cortex 55 dysrhythmias 55 serum cortisol 55 SNHL 55 prenatal exposures 55 pentoxifylline 55 DSM IV Axis 55 familial aggregation 55 semistructured interview 55 Comorbidity 55 colorectal adenoma 55 pathologic diagnosis 55 tissue oxygenation 55 immunostaining 55 HOMA IR 55 Seattle Angina Questionnaire 55 granulomatous 55 varus valgus 55 daytime alertness 55 plasma homocysteine 55 multivariable analyzes 55 ROC curves 55 serum lipid levels 55 confounding variables 55 cognitions 55 vasomotor 55 perfusion abnormalities 55 myocardial viability 55 cortical regions 55 clinico pathological 55 Insulin sensitivity 55 IIEF 55 microvessel density 55 carotid artery thickness 55 postoperative mortality 55 cortisol secretion 55 Skin sterol 55 DAS# CRP 55 Wechsler Adult 55 urine albumin 55 Genetic predisposition 55 Electroencephalography 55 serum estradiol 55 bronchial hyperresponsiveness 55 predisposing factor 55 CD# expression [001] 55 neuritic 55 sacral neuromodulation 55 multivariate logistic regression 55 thyrotropin levels 55 schizophrenia schizoaffective disorder 55 International Prostate Symptom 55 nosology 55 diabetic microvascular complications 55 adnexal mass 55 serum parathyroid hormone 55 histologic 55 tissue perfusion 55 psychiatric outpatients 55 MetS 55 amygdala reactivity 55 NNT = 55 serum IGF 55 cardiac malformations 55 cerebral infarction 55 neuropsychiatric disorders 55 callous unemotional traits 55 DSM IV diagnoses 55 NNRTI resistance 55 β blockers 55 recurrent DVT 55 generalisability 55 ventral prefrontal cortex 55 MADRS score 55 dysuria 55 clinically meaningful improvement 55 neutropaenia 55 PSQI 55 neurologic abnormalities 55 neuroleptic 55 retest reliability 55 d dimer 55 Bonferroni correction 55 parenchymal 55 chronicity 55 covariates 55 serum GGT 55 moderately heritable 55 Clinician Administered PTSD 55 TNF antagonist 55 dissociative disorders 55 hypoxemia 55 waist circumference WC 55 allele frequencies 54 obstructive coronary artery 54 perioperative complications 54 functional gastrointestinal disorders 54 nondepressed 54 multivariable Cox 54 fasting insulin 54 CIN2 + 54 posttest 54 genetic loci 54 echocardiographic parameters 54 subclinical hypothyroidism 54 confounder 54 anthropometric measures 54 anhedonia 54 parkinsonian 54 Regression analyzes 54 hypothalamic pituitary adrenal axis 54 bronchial responsiveness 54 hepatic cirrhosis 54 endotoxemia 54 BPH LUTS 54 rheumatoid factor 54 HDRS 54 depression suicidality 54 multivariate regression 54 somatization 54 pharmacologic interventions 54 Cronbach 54 secondary efficacy endpoint 54 Montgomery Asberg Depression 54 neural correlates 54 mammographically 54 postinjury 54 hypersomnia 54 nausea photophobia 54 RECIST Response Evaluation Criteria 54 NYHA functional class 54 contrast echocardiography 54 EORTC QLQ C# 54 lipid parameters 54 ADCS ADL 54 QT interval prolongation 54 prospectively stratified 54 Scale PANSS 54 EEG abnormalities 54 CD# expression [002] 54 etiological 54 oropharyngeal 54 rhinosinusitis 54 phenotypic variation 54 function subscale 54 idiopathic Parkinson disease 54 locomotor activity 54 lesional 54 PANSS 54 dopaminergic therapy 54 neoplastic 54 parasitaemia 54 mPFC 54 CDAI 54 Personality disorders 54 comorbid psychiatric disorders 54 detrusor 54 OSAHS 54 demyelinating 54 adrenal suppression 54 interrater 54 macroalbuminuria 54 Erectile function 54 decrements 54 Ocular Surface Disease 54 EEG recordings 54 Pearson correlation coefficients 54 PSA kinetics 54 neutropenia thrombocytopenia 54 serum homocysteine 54 FeNO 54 TNSS 54 dimensional sonography 54 Zevalin consolidation 54 planum temporale 54 vesicoureteral reflux 54 cerebral perfusion 54 chromosomal aberrations 54 intracerebral haemorrhage 54 predisposing factors 54 HADS 54 BLLs 54 CSF biomarkers 54 Negative Symptoms 54 alanine aminotransferase 54 poststroke depression 54 acromegalic patients 54 genomic alterations 54 eNO 54 arterial thickening 54 cortical activation 54 PLMS 54 gastric carcinoma 54 semistructured interviews 54 dysthymic disorder 54 orthostatic 54 hyperkinetic disorder 54 insula activation 54 patient subpopulations 54 obstructive sleep 54 morphometric vertebral fractures 54 CIMZIA ™ 54 OAB symptoms 54 Main Outcome Measure 54 overnight polysomnography 54 T1 weighted images 54 akathisia 54 ADAS cog 54 metaanalysis 54 lipid abnormalities 54 spondyloarthritis 54 rhinorrhea 54 untreated hypothyroidism 54 logistic regressions 54 Cochrane reviewers 54 plasma glucose concentration 54 Echocardiographic 54 infantile colic 54 neurocognition 54 plasma folate 54 cerebral oxygen saturation 54 serum retinol 54 microvascular complications 54 negative affectivity 54 serum cotinine 54 hemodilution 54 TMS Therapy 54 serum PSA 54 metabolic acidosis 54 postoperative delirium 54 GERD migraine headaches 54 adenotonsillectomy 54 Female Sexual Function 54 multiple linear regression 54 ABCB1 54 Epworth Sleepiness Scale 54 p = .# [002] 54 Subgroup analysis 54 stepwise logistic regression 54 biobehavioral 54 covariance 54 perioperative morbidity 54 nasal obstruction 54 Venous thromboembolism 54 nongenetic 54 troponin T 54 hematological parameters 54 Psoriasis Area 54 temporoparietal 54 BEXXAR Therapeutic Regimen 54 neurobehavioural 54 IUGR 54 serum ferritin 54 Glasgow Coma Scale 54 SLNB 54 inotropic 54 etiological factors 54 elevated creatinine 54 urinary N telopeptide 54 Fas ligand 54 Obsessive compulsive disorder OCD 54 habitual snoring 54 Structured Clinical 54 acoustic startle 54 generalized estimating 54 psychopathological disorders 54 lymphoma subtypes 54 F FDG PET 54 functional neuroimaging 54 glycosylated hemoglobin HbA1c 54 sonographic diagnosis 54 macrovascular disease 54 antiepileptic drugs AEDs 54 hyperplastic 54 Score IPSS 54 logistic regression 54 fractional anisotropy 54 liver histology 54 virological response 54 urinary oxalate 54 DAS# scores 54 biopsychosocial 54 hyperintensities 54 pathologic examination 54 pharmacological approaches 54 miRs 54 preoperative diagnosis 54 paresthesias 54 interobserver agreement 54 analgesic efficacy 54 myeloproliferative disorders 54 effector function 54 Endothelial function 54 Likert type 54 Comorbid 54 esophageal squamous cell carcinoma 53 differential diagnoses 53 juvenile idiopathic arthritis 53 RAPAFLO R 53 thiopurine 53 intracranial hypertension 53 histologic findings 53 coronary calcification 53 SCr 53 POAG 53 Cystatin C 53 prognostic markers 53 Scale EDSS 53 Inventory BPI 53 preoperative PSA 53 Antisocial Personality Disorder 53 neuropsychological deficits 53 vitro cytotoxicity 53 SELENA SLEDAI 53 IPAH 53 STRIDE PD 53 pCR 53 ANOVA 53 cerebral ischemia 53 androgen deficiency 53 intraclass correlation coefficient 53 vestibular dysfunction 53 enzyme immunoassay EIA 53 ventilation perfusion 53 chromosomal rearrangement 53 NIHSS score 53 sensitivity specificity 53 K ras mutations 53 venlafaxine XR 53 anaphylactic reactions bronchospasm 53 Physical Component 53 protein excretion 53 toxicologic 53 SSc 53 Exclusion criteria 53 regression coefficients 53 Severe Primary IGFD 53 myofascial trigger 53 semistructured 53 myelofibrosis polycythemia vera 53 dysphoric 53 subclinical 53 HBeAg 53 lymphovascular invasion 53 serum clusterin levels 53 MRSA isolates 53 arterial calcification 53 Pharmacokinetic parameters 53 hyperactive impulsive 53 developmental trajectories 53 amnestic MCI 53 cross sectionally 53 Secondary endpoints include 53 prostatic hyperplasia 53 pupillary 53 Y BOCS 53 histologies 53 obstructive CAD 53 cerebral oxygenation 53 antiplatelet therapies 53 pathophysiologic 53 psychopathological 53 cellularity 53 immunohistochemical staining 53 relapsed MM 53 Negative Syndrome 53 metabolic abnormalities 53 advanced adenoma 53 P cadherin 53 QoL 53 cardiac dysfunction 53 Main Outcome Measures 53 pairwise comparisons 53 metabolic derangement 53 testicular dysgenesis syndrome 53 INVEGA ® 53 akinesia 53 tic disorders 53 Kruskal Wallis test 53 opioid naïve 53 white matter hyperintensities 53 prefrontal regions 53 Dietary intakes 53 Pharmacologic 53 NMIBC 53 shorter telomere length 53 varus deformity 53 dose Iluvien 53 statistically nonsignificant 53 genital arousal 53 Comorbidities 53 #q# deletion 53 immunohistochemical 53 thyroid dysfunction 53 DSM IV TR 53 hematopoietic malignancies 53 pathophysiological processes 53 anticonvulsant medications 53 cervical neoplasia 53 chest radiographs 53 VLBW 53 hypoglycemic events 53 apolipoprotein B 53 hepatic enzymes 53 Relapsing remitting MS 53 PLMs 53 causal pathways 53 visuomotor 53 Visual Analog Scale 53 bronchoalveolar lavage BAL 53 obesity insulin resistance 53 subclinical disease 53 diagnosing ADHD 53 HPA axis 53 Sensitivity analyzes 53 insulin resistance syndrome 53 monogenic 53 oxygen saturations 53 myocardial ischaemia 53 Hamilton Anxiety Scale 53 creatinine clearance CrCl 53 artery stenosis 53 periprocedural MI 53 parasitological 53 ischemic lesions 53 cystoscopic 53 IntroductionThe 53 serum lipids 53 extracolonic findings 53 genotype phenotype 53 pretest probability 53 seminomas 53 airway reactivity 53 multivariable logistic regression 53 F FDG uptake 53 elevated fasting glucose 53 neurologic impairment 53 postoperative hemorrhage 53 physico chemical 53 premenstrual syndrome PMS 53 virologic breakthrough 53 androgen excess 53 APOE e4 53 mean ± SEM 53 Non inferiority 53 symptomology 53 CDAI score 53 comorbid diagnoses 53 nephrolithiasis 53 recurrent venous thromboembolism 53 hemostatic efficacy 53 acute subacute 53 riociguat 53 etiologies 53 pressor response 53 IgG1 antibodies 53 genotypic 53 CTEPH 53 haematuria 53 serum HBV DNA 53 postoperative complication 53 nonfatal MI 53 plasma lipids 53 calculated creatinine clearance 53 pathogenetic mechanisms 53 Pearson correlation coefficient 53 neurodevelopmental outcomes 53 UPDRS motor 53 morphologic 53 allodynia 53 mtDNA mutations 53 empirically validated 53 Cardiogenic shock 53 chest radiograph 53 CIN3 53 juvenile idiopathic arthritis JIA 53 pulmonary dysfunction 53 chi ^ sup 53 urodynamic 53 arterial oxygen saturation 53 gastric adenocarcinoma 53 venous oxygen saturation 53 evolvability 53 adrenocortical 53 differentially expressed genes 53 incidentalomas 53 airway narrowing 53 subclinical cardiovascular disease 53 viral kinetics 53 cTnT 53 Sjögren syndrome 53 ziconotide 53 chlamydial infection 53 Heterogeneity 53 Pharmacodynamic 53 psychomotor retardation 53 aminotransferase 53 serous ovarian cancer 53 ultrasonographic 53 prospectively defined 53 premenopause 53 Univariate analysis 53 Clinical manifestations 53 aspartate aminotransferase AST 53 Personality traits 53 hyperbilirubinemia 53 Angiotensin converting enzyme 53 antitumor efficacy 53 Bacterial vaginosis 53 concomitant medications 53 HeFH 53 stratifying patients 53 urinary cortisol 53 atopic eczema 53 prolactin elevation 53 statistically significant correlations 53 Longitudinal studies 53 neurological sequelae 53 sociodemographic 53 multivariable analysis 53 postoperative morbidity 53 fasting plasma 53 CHADS2 53 voiding dysfunction 53 dentinal hypersensitivity 53 variance ANOVA 53 N acetylaspartate 53 carotid artery narrowing 53 diabetes mellitus DM 53 tumor histology 53 inferential statistics 53 pathogenetic 53 vitamin D inadequacy 53 Baseline characteristics 53 compulsive hoarding syndrome 53 cardio respiratory fitness 53 FDG PET imaging 53 Hematologic toxicity 53 bronchopulmonary dysplasia 53 Coronary artery calcium 53 intrathoracic 53 prosocial behavior 53 CVD mortality 53 hypercoagulable 53 hippocampal atrophy 53 convergence insufficiency 53 suicidality 53 anxiolytic 53 hepatic fibrosis 53 noncardiac 53 Chronic insomnia 53 interferon γ 52 comorbid illnesses 52 glycated hemoglobin HbA1c 52 NIHSS 52 physiological reactions 52 tiagabine 52 mammographic density 52 O PPDS 52 overactive bladder symptoms 52 carotid plaques 52 prognostic factors 52 glutamate glutamine 52 endocannabinoid signaling 52 retinal vascular 52 oral anticoagulation 52 hypometabolism 52 baseline serum creatinine